To further investigate the correlation between PD-L1 and c-MET in EGFR-TKI resistant NSCLC, we measured the PD-L1 and c-MET expression in 15 EGFR-TKI resistant biopsies. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.